Biomerica provides update on inFoods® IBS expansion
April 15, 2024 07:47 ET
|
Biomerica, Inc.
- Expansion into new offices within current major groups, including Northeast and Ohio; Expansion into new major group in Texas. - Average quarterly increase in physicians prescribing inFoods more...
Biomerica Reports Third Quarter 2024 Financial Results
April 12, 2024 19:23 ET
|
Biomerica, Inc.
Fiscal Discipline Leads to Improvement as Loss per Share Narrows to $0.27 from $0.40 Amidst Sales Force Expansion for the Nine Months in Fiscal 2024 InFoods IBS Positive Clinical Data to be Presented...
Biomerica InFoods IBS Data to be Presented at the Upcoming Digestive Disease Week (DDW) 2024 Conference
March 28, 2024 08:19 ET
|
Biomerica, Inc.
Collaborators at the University of Michigan will present new Data on InFoods® IBS in the DDW Irritable Bowel Syndrome (IBS) Clinical Session IRVINE, Calif., March 28, 2024 (GLOBE NEWSWIRE) --...
Diagnostics Industry Leader Gary Huff Appointed to Biomerica Strategic Advisory Board
February 21, 2024 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ: BMRA), a global biomedical company leading the way in innovative gastroenterology solutions, proudly announces the...
Diagnostics Industry Leader Jack Kenny Appointed as Chairman of the Board at Biomerica
January 23, 2024 08:19 ET
|
Biomerica, Inc.
Mr. Kenny has significant executive experience and a proven track record in medical diagnostics and healthcare Mr. Kenny most recently served as CEO of Meridian Bioscience where he successfully built...
Biomerica Reports Second Quarter 2024 Financial Results
January 16, 2024 08:19 ET
|
Biomerica, Inc.
Revenues excluding Covid test sales increased 10.3% for the second fiscal quarter of 2024 vs the second fiscal quarter of 2023.Loss per shares narrows to $0.09 per share from $0.12 per share...
Biomerica Received US FDA 510(k) Clearance for Their Hp Detect™ ELISA Test Product Designed to Detect the Presence of the H. pylori Bacteria That infects Approximately 35% of the U.S. Population
December 18, 2023 07:47 ET
|
Biomerica, Inc.
Over 80% of gastric cancers are attributed to H. pylori bacterial infection Gastric cancer is the third most common cause of cancer related death in the world ...
Biomerica to Participate in 14th Annual Craig-Hallum Alpha Select Conference on November 16
November 10, 2023 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Nov. 10, 2023 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA), (the “Company”) a global provider of advanced medical products today announced that it will participate in the 14th...
Biomerica Expands inFoods IBS Reach with Addition of Several New GI Groups
November 08, 2023 08:19 ET
|
Biomerica, Inc.
Biomerica remains on track for inFoods® IBS national rollout during calendar 2024, and expects strong product revenue growth during national rolloutVeteran Vice President of Sales and National...
REPEAT - Biomerica Reports First Quarter 2024 Financial Results
October 13, 2023 13:10 ET
|
Biomerica, Inc.
Biomerica Reports First Quarter 2024 Financial Results. Revenues excluding Covid test sales increased 16.3% for first fiscal quarter of 2024